Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer

Journal of Clinical Oncology

Volumn 28, Issue 8, 2010, Pages 1308-1315

  Tukenova, Markhaba ^a   Guibout, Catherine ^a   Oberlin, Odile ^a   Doyon, Françoise ^a   Mousannif, Abdeddahir ^a   Haddy, Nadia ^a   Guérin, Sylvie ^a   Pacquement, Hélène ^a   Aouba, Albertine ^a   Hawkins, Mike ^a   Winter, Dave ^a   Bourhis, Jean ^a   Lefkopoulos, Dimitri ^a   Diallo, Ibrahima ^a   De Vathaire, Florent ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTIMETABOLITE; EPIPODOPHYLLOTOXIN; VINCA ALKALOID; ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; BONE TUMOR; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; FRANCE; GERM CELL TUMOR; HEART DISEASE; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROBLASTOMA; NEUROBLASTOMA; NEWBORN; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RETINOBLASTOMA; SCHOOL CHILD; SOFT TISSUE SARCOMA; STANDARDIZED MORTALITY RATIO; UNITED KINGDOM; VASCULAR DISEASE; ADULT; CLINICAL TRIAL; DOSE RESPONSE; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEOPLASM; RADIATION RESPONSE; RADIOTHERAPY; SURVIVOR;

ADOLESCENT; ADULT; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; FRANCE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASMS; RADIOTHERAPY; SURVIVORS;

EID: 77950498795     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.2267     Document Type: Article

References (42)

1. Mike V, Meadows AT, D'Angio GJ: Incidence of second malignant neoplasms in children : results of an international study. Lancet 8311:1326-1331, 1982 (Pubitemid 13240928)
2. Cardous-Ubbink MC, Heinen RC, Bakker PJ, et al: Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 43:351-362, 2007 (Pubitemid 46123988)
3. Garwicz S, Anderson H, Olsen JH, et al: Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 Nordic countries. Int J Cancer 88:672-678, 2000
4. de Vathaire F, Hawkins M, Cambell S, et al: Second malignant neoplasms after a first cancer in childhood: Temporal pattern of risk according to type of treatement. Br J Cancer 79:1884-1893, 1999
5. Mertens AC, Yasui Y, Neglia JP, et al: Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 19:3163-3172, 2001 (Pubitemid 32591432)
6. Möller TR, Garwicz S, Barlow L, et al: Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic countries. J Clin Oncol 19:3173-3181, 2001 (Pubitemid 32591433)
7. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al: Long-term cause specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 42:563-573, 2004 (Pubitemid 38669743)
8. MacArthur AC, Spinelli JJ, Rogers PC, et al: Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada. Pediatr Blood Cancer 48:460-467, 2007 (Pubitemid 46340114)
9. Green DM, Hyland A, Chung CS, et al: Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol 17:3207-3215, 1999 (Pubitemid 29470653)
10. Lipshultz SE, Lipsitz SR, Mone SM, et al: Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738-1743, 1995
11. Guldner L, Haddy N, Pein F, et al: Radiation dose and long-term risk of cardiac pathology following radiotherapy and anthracyclin for childhood cancer. Radiother Oncol 81:47-56, 2006 (Pubitemid 44540229)
12. Lipshultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815, 1991
13. Hancock SL, Donaldson SS, Hoppe RT: Cardiac diseases following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215, 1993 (Pubitemid 23199121)
14. Donaldson SS, Kaplan HS: Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 66:977-989, 1982 (Pubitemid 12129384)
15. Mertens AC, Lui Q, Neglia JP, et al: Cause-specific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 19:1368-1379, 2008
16. CépiDc: http://www.cepidc.vesinet.inserm.fr/index.html
17. Hawkins MM, Lancashire ER, Winter DL, et al: The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer 5:1018-1025, 2008 (Pubitemid 351500181)
18. Shamsaldin A, Grimaud E, Hardiman C, et al: Dose distribution throughout the body from radiotherapy for Hodgkin's diseases in childhood. Radiother Oncol 49:85-90, 1998 (Pubitemid 29005208)
19. Diallo I, Lamon A, Shamsaldin A, et al: Estimations of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiat Oncol 38:269-271, 1996 (Pubitemid 26079444)
20. François P, Beurtheret C, Dutreix A, et al: A mathematical child phantom for the calculation of dose to the organs at risk. Med Phys 15:328, 1988
21. François P, Beurtheret C, Dutreix A: Calculation of dose delivered to organs outside the radiation beams. Med Phys 15:879, 1988
22. Guérin S, Guibout C, Shamsaldin A, et al: Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: A case-control study. Int J Cancer 120:96-102, 2007 (Pubitemid 44901923)
23. Breslow NE, Day NE: Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ, 1-406, 1987
24. Moolgavkar SH, Venzon DJ: A method for computing profile likelihood based confidence bounds. Ann Stat 15:346-349, 1987
25. Preston DL, Lubin JH, Pierce DA, et al: EPICURE: Generalized regression models for epidemiological data. Seattle, WA, HiroSoft International, 1991
26. Emmons K, Li FP, Whitton J, et al: Predictors of smoking initiation and cessation among childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 20:1608-1616, 2002 (Pubitemid 34260542)
27. Tao ML, Guo MD, Weiss R, et al: Smoking in adult survivors of childhood acute lymphoblastic leukemia. J Natl Cancer Inst 90:219-225, 1998 (Pubitemid 28114540)
28. Haupt R, Byrne J, Connelly RR, et al: Smoking habits in survivors of childhood and adolescent cancer. Med Pediatr Oncol 20:301-306, 1992
29. Hawkins MM, Kingston JE, Kinnier Wilson LM: Late deaths after treatment for childhood cancer. Arch Dis Child 65:1356-1363, 1990
30. Robertson CM, Hawkins MM, Kingston JE: Late deaths and survival after childhood cancer. Implication for cure. BMJ 309:162-166, 1994
31. Hudson MM, Jones D, Boyett J, et al: Late mortality of long-term survivors of childhood cancer. J Clin Oncol 15:2205-2213, 1997 (Pubitemid 27251120)
32. Von Hoff DD, Layard MW, Basa P, et al: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717, 1979 (Pubitemid 10218041)
33. Pein F, Sakiroglu O, Dahan M, et al: Cardiac abnormalities 15 years and more after Adriamycin therapy in 229 childhood survivors of solid tumor at the Institut Gustave Roussy. Br J Cancer 91:37-44, 2004 (Pubitemid 39013042)
34. Swerdlow AJ, Higgins CD, Smith P, et al: Myocardial infarction mortality risk after treatment for Hodgkin disease: A Collaborative British Cohort Study. J Natl Cancer Inst 99:206-214, 2007
35. Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949-1955, 1993
36. Stewart JR, Fajardo LF: Radiation-induced heart disease: An update. Prog Cardiovasc Dis 27: 173-194, 1984 (Pubitemid 15185434)
37. Slama MS, Le Guludec D, Sebag C, et al: Complete atrioventricular block following mediastinal irradiation: A report of six cases. Pacing Clin Electrophysiol 14:1112-1128, 1991
38. Warda M, Khan A, Massumi A, et al: Radiation-induced valvular dysfunction. J Am Coll Cardiol 2:180-185, 1983 (Pubitemid 13070235)
39. Green DM, Gingell RL, Pearce J, et al: The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J Clin Oncol 5:239-245, 1987 (Pubitemid 17021606)
40. Darby S, McGale P, Peto R, et al: Mortality from cardiovascular disease more than ten years after radiotherapy for breast cancer: Nationwide cohort study of 90 000 Swedish women. BMJ 326:256-257, 2003 (Pubitemid 36169590)
41. Little MP, Tawn EJ, Tzoulaki I, et al: A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat Res 169:99-109, 2008 (Pubitemid 351295097)
42. Preston DL, Shimizu Y, Pierce DA, et al: Studies of mortality bomb survivors: Report 13-Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160:381-407, 2003